Interviews

In this video, executives from AstraZeneca and MedImmune explain why access to innovation in the development of biologics is so important.

Patrick Gleason, PharmD, BCPS, FCCP, director of Health Outcomes at Prime Therapeutics, discusses the value of pharmacogenomic testing and the factors that influence whether a health plan or PBM will reimburse for the use of that test.

Patrick Gleason, PharmD, BCPS, FCCP, director of health outcomes for Prime Therapeutics, explains how split-fill programs can help reduce waste for expensive specialty medications.

Jyoti Bhagia, MD, discusses use of a rating scale in diagnosing and treating patients with ADHD.

William A. Scott, MD, addresses the question of whether children who are initiating use of ADHD medication need to have an EKG.

Pediatrician Preeti Parikh, MD, provides an introduction to treatments for ADHD in children, including behavioral therapy, psychotherapy, family therapy, and various types of medication.

Peter Berger, MD, discusses the challenge of individualizing antiplatelet treatment for acute coronary syndrome patients.

A lecture on acute coronary syndromes by Kim A. Eagle, MD, director of the Cardiovascular Center at the University of Michigan Health System.

Jeffrey Berger, MD, discusses how research can help increase adherence to therapies among acute coronary syndrome patients.

A discussion of requirements for distributing medication guides when a drug is dispensed or distributed to a health care professional.

An animated video demonstrating how influenza virus enters a human cell, penetrates the nucleus, replicate itself, and emerges to infect other cells.

A discussion of high blood pressure and measures that can be taken to counter it, including prescription medication.

A discussion of efforts to develop a universal influenza vaccine that will be capable of protecting against any potential strain of the influenza virus.

Kurtis Reed, MD, discusses the results of his study on the incidence of melanoma among young adults.

This video from the National Institute of Allergy and Infectious Diseases discusses the causes of influenza pandemics.

Professor Dusheiko talks about managing HCV patients with cirrhosis.

Here, UCSF's Annie Luetkemeyer talks about new treatments for hepatitis C and what they will do for people with infections.

FHI 360 President Emeritus Ward Cates discusses the HIV treatment cascade. This model aims to bring us closer to the end of AIDS by addressing the gaps in the HIV diagnosis and treatment system currently in place.

Arun K. Ghosh. professor of organic and medicinal chemistry at Purdue University, talks with Hiroaki Mitsuya, Head of Experimental Retrovirology Section at the National Cancer Institute, about HIV drug development.

Dr. Paul Richardson discusses promising drugs in the pipeline for the treatment of myeloma and new combination treatments using older drugs.

This video describes the use of targeted therapies for the treatment of multiple myeloma.

Are corticosteroids still the number one drug for inducing clinical remission in IBD?

This is the first webcast series from the Crohn's & Colitis Foundation of America targeted to health care professionals.

Video from the National Multiple Sclerosis Society with the message, "MS Kills Connection. Connection Kills MS."

This study discusses various treatments for multiple sclerosis, with a specific focus on alternative strategies like CCSVI.

This video summarizes the research findings from ECTRIMS 2012.

This video, from the Cleveland Clinic, discusses a syndrome in which generally healthy people who drink more than usual at the holidays can experience heart problems.

A discussion of an FDA warning regarding the potential for cognitive problems and elevated blood sugar associated with taking statins.

Doug Long, vice president of industry relations at IMS Health, discusses his predictions for the 2012-2013 flu season.